FIELD: biotechnology.
SUBSTANCE: methods are proposed for modifying a eukaryotic organism by manipulating a target sequence in a genome locus of interest by using the CRISPR-Cas system, as well as a method of treating or inhibiting a condition caused by a defect in a target sequence, and a composition containing components of said system.
EFFECT: present invention enables the change of genomic loci of the eukaryotic cell by using Cas9 nuclease fused with one or more nuclear localization sequences (NLS).
21 cl, 73 dwg, 35 tbl, 37 ex
Title | Year | Author | Number |
---|---|---|---|
SYSTEM DESIGN, METHODS AND OPTIMIZED GUIDE COMPOSITIONS FOR SEQUENCE MANIPULATION | 2013 |
|
RU2796017C2 |
COMPONENTS OF THE CRISPR-CAS SYSTEM, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | 2013 |
|
RU2796549C2 |
NEW ENZYMES AND CRISPR SYSTEMS | 2016 |
|
RU2777988C2 |
RNA-GUIDED TRANSCRIPTION REGULATION | 2014 |
|
RU2756865C2 |
DELIVERY, CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED ACTION AND MODELING OF DISEASES AND DISORDERS OF POSTMITOTIC CELLS | 2014 |
|
RU2725502C2 |
NEW CRISPR ENZYMES AND SYSTEMS | 2016 |
|
RU2771826C2 |
DELIVERY, USE AND USE IN THERAPY OF CRISPR-CAS SYSTEMS AND COMPOSITIONS FOR TARGETED ACTION ON DISORDERS AND DISEASES USING VIRAL COMPONENTS | 2014 |
|
RU2716421C2 |
GENOMIC ENGINEERING | 2014 |
|
RU2764757C2 |
GENOME ENGINEERING | 2021 |
|
RU2812848C2 |
CRISPR/CAS9 TYPE II GENOME EDITING SYSTEM AND ITS USE | 2022 |
|
RU2794774C1 |
Authors
Dates
2020-05-18—Published
2013-12-12—Filed